beta

ADPT

Adaptive Biotechnologies Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.

Market Cap: 3.76 Billion

Primary Exchange: NASDAQ

Website: http://www.adaptivebiotech.com

Shares Outstanding: 124 Million

Float: 115 Million

Dividend: (%)

Beta: 0.0885148724948963

Sector: Commercial Services

Industry: Miscellaneous Commercial Services

Ethical Flags

Longest drawdown: 84 trading days

From: 2019-09-04 To: 2019-12-13

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud